BHC

NYSE Healthcare

Bausch Health Companies Inc. Common Stock

Drug Manufacturers - Specialty & Generic

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

🎯 投资策略评分

BHC 在各投资策略中的评分。分数越高,越符合该策略目标。

高股息率 + 低波动性
高增长潜力(高贝塔 + 超卖)
逆向投资(超卖 + 低于移动均线)
超买股票(潜在做空标的)
大盘、机构级别股票
🔍 策略解读

最佳匹配: 🔪 Falling Knife (92/100) — 此策略 逆向投资(超卖 + 低于移动均线).

评分最低的策略: 🎈 Over-Hyped (11/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →

在文本中查找 BHC in your text

粘贴任何文章、记录或帖子 — 工具将提取 BHC 以及每一个其他隐藏的股票代码。

试试股票代码提取器 →

免责声明:本数据仅供教育和娱乐用途,不构成金融建议。市场数据可能存在延迟。在做出投资决策之前,请始终进行自己的研究。
数据最后更新: 2026-06-02.